In the risk assessment of patients considered for non‐cardiac surgery and with recent coronary stent implantation, coronary drug‐eluting stent implantation procedure characteristics may be taken into account. We aimed to… Click to show full abstract
In the risk assessment of patients considered for non‐cardiac surgery and with recent coronary stent implantation, coronary drug‐eluting stent implantation procedure characteristics may be taken into account. We aimed to evaluate associations between coronary drug‐eluting stent implantation procedure characteristics and the risk of myocardial infarction and all‐cause death within 30 days after non‐cardiac surgery.
               
Click one of the above tabs to view related content.